AGC Biologics will be in Yokohama, next week, for the Japan Society of Gene and Cell Therapy meeting. We look forward to exploring potential pathways and innovations through gene and cell therapy modalities. Find Kengo Suyama, Naoko Suzuki, Eunjin Seul, and Ayako Kashima at booth #22, during the show. Visit our website to set up a meeting with them and learn more about our presence. https://lnkd.in/gchVtbJ9 #biotech #pharma #Biopharma #pharmaceuticals #LifeScience #Biotechnology #biologics #Biopharmaceuticals #AGCBio #CDMO
AGC Biologics
Biotechnology Research
Bothell, WA 96,804 followers
We work side by side with our customers to improve patients’ lives by bringing new biopharmaceutical products to market.
About us
AGC Biologics offers deep industry expertise and uniquely customized services for the scale-up and cGMP manufacture of protein-based therapeutics (using mammalian and microbial systems), mRNA, pDNA, viral vector and cell therapy products, from pre-clinical to commercial production, including our proprietary CHEF1TM Expression System for efficient protein production with CHO cells. Our company DNA drives us to provide innovative solutions to partner with our customers in helping them reach their goals and accelerate their projects at our cGMP-compliant facilities in the US, Europe and Japan, as well as to facilitate approval and manage spending during the product lifecycle. We forge exceptionally strong partnerships with our customers and we never lose sight of our commitment to deliver reliable and compliant drug substance. Visit www.agcbio.com to learn more.
- Website
-
http://www.agcbio.com
External link for AGC Biologics
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Bothell, WA
- Type
- Public Company
- Specialties
- Mammalian Cell Line Development, Microbial Cell Line Development, Upstream Process Development, Downstream Process Development, Analytical Development, Formulation Development, cGMP Manufacturing, GMP Stability Studies and Storage, CHEF1 Expression System, Perfusion, Gene Therapy, Viral Vector, Cell Therapy, pDNA, plasmidDNA, mRNA, and Advanced Therapy
Locations
Employees at AGC Biologics
Updates
-
AGC Biologics meets diverse viral vector demands in gene therapy through standardized platform processes like ProntoLVV™ and BravoAAV™, supporting scalable production up to 2,000 L. Dr. Martina Brunati iterates why adaptability and rapid response are critical in meeting developer needs, emphasizing how a platform approach enhances efficiency and quality. Through this templated yet adaptable approach, our cell and gene experts have created robust, GMP-compliant processes from development to commercialization in advanced gene therapies. Read our latest blog, find the link in the comments below! #biotech #pharma #Biopharma #pharmaceuticals #LifeScience #Biotechnology #biologics #Biopharmaceuticals #AGCBio #CDMO
-
-
This week, our #FridayFeature is Iván Martínez Monge (he/him), Principal Scientist in the Upstream Process Development Department. With three years at AGC Biologics, Iván loves the diverse processes he engages with, from mammalian to microbial, and finds motivation in knowing he is helping to bring new biopharmaceuticals to market for patients. Iván deeply connects with our core values of #knowledge and #teamwork. Throughout his career, he has focused on understanding cell behavior in bioreactors and he strives to inspire his colleagues with his knowledge and enthusiasm. Recently, Iván represented AGC Biologics at the European Society of Animal Cell Technology Congress 2024, sharing his insights with the industry. Outside of work, Iván is an avid ultra-trail runner, having completed the 170 km Ultra Trail du Mont-Blanc. He enjoys traversing mountains, valleys, and forests, embracing the beauty of nature. Thank you for your expertise and passion, Iván Martínez-Monge! We are happy to have you on the AGC Bio team. #AGCBio #EmployeeSpotlight #CoreValues
-
As we commemorate the 4th of July, AGC Biologics takes a moment to reflect on the profound significance of this day in American history. It's a time to honor the values of freedom, unity, and resilience. Wishing our team members at our Seattle headquarters and Colorado locations a happy and safe Independence Day, filled with celebration.
-
-
Scaling up from R&D to full-scale manufacturing often requires meticulous process optimization to address challenges like titration and precipitation and ensure high-quality final production. 𝐈𝐧 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐛𝐥𝐨𝐠: we explore what makes a good downstream purification team at a CDMO work, and why flexibility and experience are two things you must be looking for to keep a project on track. Click the link in the comment below to read today! #biotech #pharma #Biopharma #pharmaceuticals #LifeScience #Biotechnology #biologics #Biopharmaceuticals #AGCBio #CDMO
-
-
AGC Biologics is in Jeju, South Korea for the 2024 Bio-Partnering and Investment Forum. Find Eunjin Seul at the event! She is ready to discuss and learn more about your upcoming biopharmaceutical project. Visit our website to set up a meeting with her and learn more about our presence. https://lnkd.in/g3v8uKgi #biotech #pharma #Biopharma #pharmaceuticals #LifeScience #Biotechnology #biologics #Biopharmaceuticals #AGCBio #CDMO
-
-
Discover a seamless solution for your ADC needs with AGC Biologics and PROVEO's global partnership. With top-tier cGMP commercial manufacturing facilities across three continents, a stellar regulatory history, and over 200 biologics successfully developed, we're your all-in-one partner. Explore how our collaboration ensures a smooth journey from phase 1 to fill and finish, delivering results efficiently and confidently: https://lnkd.in/dxsMf-57 #biotech #pharma #Biopharma #pharmaceuticals #LifeScience #Biotechnology #biologics #Biopharmaceuticals #AGCBio #CDMO
-
-
AGC Biologics' is excited to present at the European Society of Animal Cell Technology Congress 2024 in Edinburgh and showcase our collaborative poster with VarmX. Presenting this poster are two members of Copenhagen's Upstream Process Development team, Iván Martínez Monge and Tamanna Nagraik. Learn what strategies we used to enhance productivity, including metabolic analysis of media components to identify pathways for higher yields in perfusion culture, to make VMX-C001 more accessible to the market. Visit our poster #367 today before the show ends! #biotech #pharma #Biopharma #pharmaceuticals #LifeScience #Biotechnology #biologics #Biopharmaceuticals #AGCBio #CDMO
-
-
Hello Tokyo! AGC Biologics is here for INTERPHEX Week Tokyo and our team is ready to discuss and learn more about your upcoming biopharmaceutical project. Shigeru Kunii, Kengo Suyama, Ayako Kashima, and Eunjin Seul are at the show and available to discuss your upcoming project needs, you can find them at Booth F37 in the CDMO area. Visit our website to set up a meeting with them and learn more about our presence. https://lnkd.in/gJhMnrWH #biotech #pharma #Biopharma #pharmaceuticals #LifeScience #Biotechnology #biologics #Biopharmaceuticals #AGCBio #CDMO
-
-
Did you hear? AGC Biologics and BioConnection are collaborating to support manufacturing capabilities for large pharma, mid-size biotech, and startup developers. Alexander Willemse, CEO of BioConnection, commented, "We are excited to join forces with AGC Biologics to offer integrated manufacturing solutions that address the complexities of biopharmaceutical development. Together, we are well-positioned to support our clients at every stage of the product lifecycle." Learn more about this seamless solution for development and manufacturing, from early-stage development through commercialization. https://lnkd.in/gHqNacKN #biotech #pharma #Biopharma #pharmaceuticals #LifeScience #Biotechnology #biologics #Biopharmaceuticals #AGCBio #CDMO
-